E. Coli Antibiotic Resistance Trends in ICU and Non-ICU Patients

17 antibiotic susceptibility tests were performed on Escherichia coli samples from ICU and non-ICU patients in Guizhou, China. The dataset contains counts and positive rates for infection, ESBL production, comprehensive drug resistance, and multidrug resistance. Zeling Dong published this analysis on figshare in April 2026.

Use Cases

• Analyze correlation between E. coli infection rates and ESBL-positive rates using time-series data.
• Compare comprehensive drug resistance rates across 17 antimicrobial agents between ICU and non-ICU patient samples.
• Model trends in multidrug resistance (MDR) rates relative to ICU detection rates.
• Examine the relationship between declining infection rates and changes in drug resistance patterns.

Strengths

• Data includes results for 17 different antibiotics, providing a broad resistance profile.
• Analysis distinguishes between ICU and non-ICU patient populations for comparative study.

Limitations

• Dataset size is 9.5 KB, indicating a limited number of aggregated summary records, not individual patient data.
• Geographic scope is restricted to Guizhou, China, limiting generalizability.
• Specific row counts, sample sizes, and individual column data are not provided.

Provenance

Source

figshare, authored by Zeling Dong.

Collection Method

Bacterial identification and drug susceptibility testing performed using the VITEK-2 Compact system on samples from outpatients and inpatients.

Time Range

null

Freshness

Last updated April 2026.

Geography

Guizhou, China.